Ed Arce

Stock Analyst at HC Wainwright & Co.

(1.57)
# 1580
Out of 5,370 analysts
598
Total ratings
44.93%
Success rate
11.39%
Average return
57 Stocks
Name Action PT Current % Upside Ratings Updated
TVTX Travere Therapeutics
Assumes: Buy
30
14.73 103.67% 21 Jun 11, 2025
MTVA MetaVia
Reiterates: Buy
12 12
0.74 1521.62% 3 Apr 16, 2025
UNCY Unicycive Therapeuti...
Reiterates: Buy
8 8
0.75 900% 27 Apr 11, 2025
ARCT Arcturus Therapeutic...
Reiterates: Buy
60 60
12.89 365.48% 31 Apr 10, 2025
AKBA Akebia Therapeutics
Reiterates: Buy
8 8
3.56 110.67% 36 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
3.32 291.57% 16 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 17 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
n/a n/a 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
8.1 764.2% 6 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 13 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 8 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
n/a n/a 17 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 24 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32
7.3 338.36% 11 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
24 35
22.5 55.56% 22 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 75
55.47 35.21% 25 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
29 21
10.03 109.37% 22 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 72
50.3 43.14% 30 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
400 405
284.98 42.12% 17 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
6 6
3.67 49.86% 9 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95 95
37.03 156.55% 6 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
7.26 147.93% 11 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
4.1 217.07% 18 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
3.58 39.66% 18 Jan 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48 48
19.75 143.04% 2 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8 8
4.01 87.03% 11 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1 400% 13 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
8.13 59.9% 16 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
12 240
0.64 37400% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 8 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
33
n/a n/a 20 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
21.85 14.42% 8 Dec 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 8 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
3
n/a n/a 12 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
40
n/a n/a 4 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 5 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
42
n/a n/a 10 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 69
n/a n/a 1 May 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6 2
n/a n/a 4 Mar 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 39
n/a n/a 8 Nov 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Oct 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13500 14625
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1750 0
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 3, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
2188
n/a n/a 4 May 31, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 15
n/a n/a 3 Mar 22, 2019